Apalutamide Not Yet Recruiting Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03777982Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
NCT03488810Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer